title: The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7.
abstract: A20 possesses both deubiquitinase (DUB) and ubiquitin E3 ligase activities that are required for termination of Toll-like receptor (TLR) signaling leading to NF-kappaB activation and for blockage of tumor necrosis factor (TNF)-induced cytotoxicity and apoptosis. A20 is induced by the Epstein-Barr virus (EBV) oncoprotein LMP1. However, its dual ubiquitin-editing activities have not been investigated in the context of either EBV infection or IRF7 responses. Both A20 and IRF7 have oncogenic properties. We have recently shown that LMP1 activates IRF7 through K63-linked ubiquitination which requires RIP1 and TRAF6, but how this ubiquitination event is regulated has not been studied. Here, we show that A20 negatively regulates IRF7 transcriptional activity induced by LMP1. Deletion or mutation of A20 C-terminal zinc finger motifs had no effect on the inhibition of IRF7 activity, whereas DUB-deficient truncation or point mutation ablated the ability of A20 to inhibit IRF7. Correspondingly, the A20 N-terminal DUB domain, but not the C-terminal E3 ligase domain, interacts physically with IRF7. Transient expression of A20 reduced K63-linked ubiquitination of IRF7 in vivo, but an in vitro deubiquitination assay with purified constituents shows that IRF7 did not act as a substrate for A20 DUB activity. Moreover, A20 interacts with IRF7 endogenously in latently EBV-infected type 3 Raji cells, in which expression of both A20 and IRF7 is constitutively induced by the considerable level of endogenous LMP1. Knockdown of endogenous A20 in Raji cells by expression of A20 short hairpin RNA (shRNA) vectors increases endogenous IRF7 activity and ubiquitination, as well as the protein level of LMP1, a target of IRF7. Thus, A20 negatively regulates LMP1-stimulated IRF7 ubiquitination and activity in EBV latency, and its DUB activity is indispensable for this function. Finally, we discussed the regulation and function of IRFs in EBV latency.
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Miller School of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA. sning@med.miami.edu
authors.forename: Shunbin
authors.initials: S
authors.lastname: Ning
authors.forename: Joseph S
authors.initials: JS
authors.lastname: Pagano
mesh_terms: D045744:Cell Line, Tumor; D004268:DNA-Binding Proteins; D020031:Epstein-Barr Virus Infections / Q000235:genetics / Q000378:metabolism*; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D050839:Interferon Regulatory Factor-7 / Q000235:genetics / Q000378:metabolism*; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics / Q000378:metabolism*; D009687:Nuclear Proteins / Q000235:genetics / Q000378:metabolism*; D000072598:Tumor Necrosis Factor alpha-Induced Protein 3; D054875:Ubiquitination; D014763:Viral Matrix Proteins / Q000235:genetics / Q000378:metabolism*
chemical_list: D004268:DNA-Binding Proteins; C037662:EBV-associated membrane antigen, Epstein-Barr virus; C494234:IRF7 protein, human; D050839:Interferon Regulatory Factor-7; D047908:Intracellular Signaling Peptides and Proteins; D009687:Nuclear Proteins; D014763:Viral Matrix Proteins; C076529:TNFAIP3 protein, human; D000072598:Tumor Necrosis Factor alpha-Induced Protein 3
references.citation: Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15989-94
references.pmid: 16236719
references.citation: Mol Cell Biol. 2004 Jun;24(12):5089-93
references.pmid: 15169876
references.citation: Pharmacol Ther. 2009 Nov;124(2):219-34
references.pmid: 19615405
references.citation: Annu Rev Biochem. 2009;78:399-434
references.pmid: 19489725
references.citation: Immunol Lett. 2009 Jan 29;122(1):1-11
references.pmid: 19059436
references.citation: J Virol. 2005 Feb;79(3):1724-33
references.pmid: 15650197
references.citation: Immunity. 2006 Sep;25(3):373-81
references.pmid: 16979569
references.citation: PLoS One. 2009;4(5):e5500
references.pmid: 19430534
references.citation: J Biol Chem. 2006 Jan 27;281(4):2095-103
references.pmid: 16306043
references.citation: Cell. 2009 Aug 7;138(3):576-91
references.pmid: 19631370
references.citation: Nat Immunol. 2004 Oct;5(10):1052-60
references.pmid: 15334086
references.citation: Nat Rev Immunol. 2006 Sep;6(9):644-58
references.pmid: 16932750
references.citation: Mol Cell. 2009 Feb 13;33(3):275-86
references.pmid: 19217402
references.citation: PLoS One. 2009 Jun 18;4(6):e5955
references.pmid: 19536331
references.citation: Nat Rev Immunol. 2008 Jul;8(7):559-68
references.pmid: 18575461
references.citation: Oncogene. 2005 Mar 3;24(10):1711-7
references.pmid: 15674340
references.citation: Blood. 2009 Apr 2;113(14):3264-75
references.pmid: 18952891
references.citation: Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15572-6
references.pmid: 14663138
references.citation: EMBO J. 2009 Mar 4;28(5):513-22
references.pmid: 19131965
references.citation: Biochem J. 2005 Apr 1;387(Pt 1):47-55
references.pmid: 15527421
references.citation: J Virol. 2000 Feb;74(3):1061-8
references.pmid: 10627515
references.citation: J Gen Virol. 2008 Jan;89(Pt 1):1-47
references.pmid: 18089727
references.citation: Mol Cell Biol. 2008 Oct;28(20):6536-46
references.pmid: 18710948
references.citation: Virology. 1999 Nov 10;264(1):159-66
references.pmid: 10544141
references.citation: Mol Cell Biol. 2007 Nov;27(21):7451-61
references.pmid: 17709380
references.citation: Semin Cancer Biol. 2008 Dec;18(6):423-36
references.pmid: 18948197
references.citation: Mol Cell Biol. 1997 Feb;17(2):873-86
references.pmid: 9001242
references.citation: J Immunol. 2005 Feb 1;174(3):1507-12
references.pmid: 15661910
references.citation: BMC Biochem. 2007 Nov 22;8 Suppl 1:S8
references.pmid: 18047745
references.citation: Mol Cell Biol. 2007 Apr;27(8):2910-8
references.pmid: 17296724
references.citation: J Virol. 2008 Jul;82(13):6251-8
references.pmid: 18417578
references.citation: Nature. 2007 Jul 26;448(7152):501-5
references.pmid: 17618271
references.citation: Nat Rev Immunol. 2006 Nov;6(11):823-35
references.pmid: 17063184
references.citation: PLoS One. 2009 Aug 26;4(8):e6764
references.pmid: 19707515
references.citation: Mol Cell Biol. 1997 Oct;17(10):5748-57
references.pmid: 9315633
references.citation: Oncogene. 1997 Jun 19;14(24):2899-916
references.pmid: 9205097
references.citation: Semin Immunol. 2009 Aug;21(4):215-22
references.pmid: 19539500
references.citation: J Virol. 2008 Nov;82(21):10477-86
references.pmid: 18715931
references.citation: J Virol. 2008 Nov;82(21):10436-43
references.pmid: 18753206
references.citation: J Virol. 1996 Dec;70(12):8653-9
references.pmid: 8970991
references.citation: Blood. 2009 Sep 17;114(12):2467-75
references.pmid: 19608751
references.citation: Nat Rev Mol Cell Biol. 2009 Aug;10(8):550-63
references.pmid: 19626045
references.citation: Mol Cell Biol. 1999 Apr;19(4):3216-23
references.pmid: 10082588
references.citation: J Exp Med. 2003 Oct 6;198(7):1043-55
references.pmid: 14517278
references.citation: Nat Immunol. 2009 Nov;10(11):1200-7
references.pmid: 19801985
references.citation: Oncogene. 2006 Jan 12;25(2):288-97
references.pmid: 16247482
references.citation: J Biol Chem. 2005 Apr 1;280(13):12262-70
references.pmid: 15664995
references.citation: N Engl J Med. 2002 Jul 11;347(2):78-9
references.pmid: 12110734
references.citation: J Biomed Sci. 2003 Sep-Oct;10(5):490-504
references.pmid: 12928589
references.citation: Nature. 2004 Aug 5;430(7000):694-9
references.pmid: 15258597
references.citation: J Virol. 2009 May;83(9):4345-53
references.pmid: 19244336
references.citation: J Virol. 2005 Sep;79(18):11671-6
references.pmid: 16140744
references.citation: Science. 2007 Dec 7;318(5856):1628-32
references.pmid: 17991829
references.citation: J Virol. 2007 Sep;81(18):9748-58
references.pmid: 17609264
references.citation: J Biol Chem. 1992 Dec 5;267(34):24157-60
references.pmid: 1332946
references.citation: J Biol Chem. 1990 Sep 5;265(25):14705-8
references.pmid: 2118515
references.citation: J Virol. 2003 Sep;77(17):9359-68
references.pmid: 12915551
references.citation: J Immunol. 2007 Feb 15;178(4):2429-39
references.pmid: 17277150
references.citation: Nat Immunol. 2008 Mar;9(3):254-62
references.pmid: 18246070
references.citation: FEBS Lett. 2004 Oct 8;576(1-2):86-90
references.pmid: 15474016
references.citation: J Biol Chem. 2006 Apr 7;281(14):9163-9
references.pmid: 16469740
references.citation: J Exp Med. 2009 May 11;206(5):981-9
references.pmid: 19380639
references.citation: Essays Biochem. 2005;41:139-56
references.pmid: 16250903
references.citation: J Virol. 2001 Jan;75(1):341-50
references.pmid: 11119603
references.citation: Nat Immunol. 2009 Oct;10(10):1073-80
references.pmid: 19701189
references.citation: Nat Immunol. 2009 Oct;10(10):1065-72
references.pmid: 19609254
references.citation: Nat Rev Drug Discov. 2007 Dec;6(12):975-90
references.pmid: 18049472
references.citation: PLoS Pathog. 2008 Oct 03;4(10):e1000170
references.pmid: 18833293
references.citation: Nature. 2009 Mar 26;458(7237):430-7
references.pmid: 19325622
references.citation: Nat Rev Mol Cell Biol. 2009 Jun;10(6):398-409
references.pmid: 19436320
references.citation: Nat Rev Immunol. 2008 Jul;8(7):501-11
references.pmid: 18535581
references.citation: Mol Cell Biol. 2008 Aug;28(16):5027-42
references.pmid: 18573890
references.citation: FEBS Lett. 2009 May 19;583(10):1567-74
references.pmid: 19379743
references.citation: J Virol. 1997 Sep;71(9):6887-97
references.pmid: 9261415